UPDATED Jul 10, 2025
Discover Egyptian Pharmaceuticals & Biotech Growth Stocks that are on the CASE/EGX. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
RMDA | ج.م4.53 | 2.7% | 95.3% | ج.م6.8b | ج.م7.58 | PE17.5x | E27.5% | 1.5% | ||
PHAR | ج.م52.47 | 3.3% | 35.2% | ج.م7.8b | ج.م90.00 | PE9.6x | E25.6% | 2.9% | ||
ADCI | ج.م102.58 | 3.0% | 150.2% | ج.م1.2b | n/a | PE7.8x | n/a | 8.1% | ||
NIPH | ج.م57.76 | 18.9% | -16.4% | ج.م584.8m | n/a | PE6.3x | n/a | 6.4% | ||
MIPH | ج.م232.86 | -0.5% | 21.3% | ج.م2.7b | n/a | PE21.4x | n/a | 0.7% | ||
OCPH | ج.م115.25 | 2.7% | 15.3% | ج.م1.4b | n/a | PE10x | n/a | 2.2% | ||
AXPH | ج.م485.81 | 8.6% | 130.6% | ج.م2.4b | n/a | PE7.9x | n/a | 6.2% | ||
BIOC | ج.م41.24 | 7.8% | 44.3% | ج.م3.4b | n/a | PE14.2x | n/a | 1.8% | ||
SIPC | ج.م2.31 | 44.4% | 243.2% | ج.م577.5m | n/a | PS25.4x | n/a | 0% | ||
CPCI | ج.م176.55 | -1.5% | 152.7% | ج.م2.6b | n/a | PE6.5x | n/a | 7.3% | ||
MPCI | ج.م81.35 | 9.2% | -4.4% | ج.م1.9b | n/a | PE4.6x | n/a | 4.9% |